208 related articles for article (PubMed ID: 16084644)
21. Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice.
Ganesh S; Delgado-Escueta AV; Sakamoto T; Avila MR; Machado-Salas J; Hoshii Y; Akagi T; Gomi H; Suzuki T; Amano K; Agarwala KL; Hasegawa Y; Bai DS; Ishihara T; Hashikawa T; Itohara S; Cornford EM; Niki H; Yamakawa K
Hum Mol Genet; 2002 May; 11(11):1251-62. PubMed ID: 12019206
[TBL] [Abstract][Full Text] [Related]
22. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy.
Minassian BA; Lee JR; Herbrick JA; Huizenga J; Soder S; Mungall AJ; Dunham I; Gardner R; Fong CY; Carpenter S; Jardim L; Satishchandra P; Andermann E; Snead OC; Lopes-Cendes I; Tsui LC; Delgado-Escueta AV; Rouleau GA; Scherer SW
Nat Genet; 1998 Oct; 20(2):171-4. PubMed ID: 9771710
[TBL] [Abstract][Full Text] [Related]
23. Cell death pathways differ in several mouse models with motoneurone disease: analysis of pure motoneurone populations at a presymptomatic age.
Perrin FE; Boisset G; Lathuilière A; Kato AC
J Neurochem; 2006 Sep; 98(6):1959-72. PubMed ID: 16831193
[TBL] [Abstract][Full Text] [Related]
24. Mutation spectrum and predicted function of laforin in Lafora's progressive myoclonus epilepsy.
Minassian BA; Ianzano L; Meloche M; Andermann E; Rouleau GA; Delgado-Escueta AV; Scherer SW
Neurology; 2000 Aug; 55(3):341-6. PubMed ID: 10932264
[TBL] [Abstract][Full Text] [Related]
25. Lafora's disease: towards a clinical, pathologic, and molecular synthesis.
Minassian BA
Pediatr Neurol; 2001 Jul; 25(1):21-9. PubMed ID: 11483392
[TBL] [Abstract][Full Text] [Related]
26. Laforin and malin deletions in mice produce similar neurologic impairments.
García-Cabrero AM; Marinas A; Guerrero R; de Córdoba SR; Serratosa JM; Sánchez MP
J Neuropathol Exp Neurol; 2012 May; 71(5):413-21. PubMed ID: 22487859
[TBL] [Abstract][Full Text] [Related]
27. Ontogeny of Lafora bodies and neurocytoskeleton changes in Laforin-deficient mice.
Machado-Salas J; Avila-Costa MR; Guevara P; Guevara J; Durón RM; Bai D; Tanaka M; Yamakawa K; Delgado-Escueta AV
Exp Neurol; 2012 Jul; 236(1):131-40. PubMed ID: 22542948
[TBL] [Abstract][Full Text] [Related]
28. Differential brain transcriptome of beta4 nAChR subunit-deficient mice: is it the effect of the null mutation or the background strain?
Kedmi M; Orr-Urtreger A
Physiol Genomics; 2007 Jan; 28(2):213-22. PubMed ID: 16985005
[TBL] [Abstract][Full Text] [Related]
29. Trehalose Ameliorates Seizure Susceptibility in Lafora Disease Mouse Models by Suppressing Neuroinflammation and Endoplasmic Reticulum Stress.
Sinha P; Verma B; Ganesh S
Mol Neurobiol; 2021 Mar; 58(3):1088-1101. PubMed ID: 33094475
[TBL] [Abstract][Full Text] [Related]
30. Glycogen metabolism in tissues from a mouse model of Lafora disease.
Wang W; Lohi H; Skurat AV; DePaoli-Roach AA; Minassian BA; Roach PJ
Arch Biochem Biophys; 2007 Jan; 457(2):264-9. PubMed ID: 17118331
[TBL] [Abstract][Full Text] [Related]
31. Loss of laforin or malin results in increased Drp1 level and concomitant mitochondrial fragmentation in Lafora disease mouse models.
Upadhyay M; Agarwal S; Bhadauriya P; Ganesh S
Neurobiol Dis; 2017 Apr; 100():39-51. PubMed ID: 28063983
[TBL] [Abstract][Full Text] [Related]
32. A novel exon 3 mutation in a Tunisian patient with Lafora's disease.
Khiari HM; Lesca G; Malafosse A; Mrabet A
J Neurol Sci; 2011 May; 304(1-2):136-7. PubMed ID: 21371719
[TBL] [Abstract][Full Text] [Related]
33. Molecular characterization of laforin, a dual-specificity protein phosphatase implicated in Lafora disease.
Girard JM; Lê KH; Lederer F
Biochimie; 2006 Dec; 88(12):1961-71. PubMed ID: 17010495
[TBL] [Abstract][Full Text] [Related]
34. Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagy.
Criado O; Aguado C; Gayarre J; Duran-Trio L; Garcia-Cabrero AM; Vernia S; San Millán B; Heredia M; Romá-Mateo C; Mouron S; Juana-López L; Domínguez M; Navarro C; Serratosa JM; Sanchez M; Sanz P; Bovolenta P; Knecht E; Rodriguez de Cordoba S
Hum Mol Genet; 2012 Apr; 21(7):1521-33. PubMed ID: 22186026
[TBL] [Abstract][Full Text] [Related]
35. Escherichia coli expression, refolding and characterization of human laforin.
Castanheira P; Moreira S; Gama M; Faro C
Protein Expr Purif; 2010 Jun; 71(2):195-9. PubMed ID: 20152902
[TBL] [Abstract][Full Text] [Related]
36. Differential gene expression in Ndph-knockout mice in retinal development.
Schäfer NF; Luhmann UF; Feil S; Berger W
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):906-16. PubMed ID: 18978344
[TBL] [Abstract][Full Text] [Related]
37. Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype.
Ganesh S; Delgado-Escueta AV; Suzuki T; Francheschetti S; Riggio C; Avanzini G; Rabinowicz A; Bohlega S; Bailey J; Alonso ME; Rasmussen A; Thomson AE; Ochoa A; Prado AJ; Medina MT; Yamakawa K
Hum Mol Genet; 2002 May; 11(11):1263-71. PubMed ID: 12019207
[TBL] [Abstract][Full Text] [Related]
38. FoxO3a-mediated autophagy is down-regulated in the laforin deficient mice, an animal model for Lafora progressive myoclonus epilepsy.
Jain N; Mishra R; Ganesh S
Biochem Biophys Res Commun; 2016 May; 474(2):321-327. PubMed ID: 27107699
[TBL] [Abstract][Full Text] [Related]
39. Genes and pathways differentially expressed in the brains of Fxr2 knockout mice.
Cavallaro S; Paratore S; Fradale F; de Vrij FM; Willemsen R; Oostra BA
Neurobiol Dis; 2008 Dec; 32(3):510-20. PubMed ID: 18930145
[TBL] [Abstract][Full Text] [Related]
40. Gene expression patterns in brain cortex of three different animal models of depression.
Urigüen L; Arteta D; Díez-Alarcia R; Ferrer-Alcón M; Díaz A; Pazos A; Meana JJ
Genes Brain Behav; 2008 Aug; 7(6):649-58. PubMed ID: 18363858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
